Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gastroesophageal Reflux × linaclotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Opioid-Induced Constipation 1 Gastrointestinal Neoplasms 1 Gastroesophageal Reflux 1 Colorectal Neoplasms 1 Barrett Esophagus 1

Interventions

Endoscopy, Digestive System 4 Endoscopy 3 Biopsy 3 YF 476 2 Specimen Handling 2 plecanatide 1 linaclotide 1 ilaprazole 1 Quality of Life 1 Lysine Acetyltransferase 5 1 Gastropexy 1 Fundoplication 1 Esomeprazole 1 Endoscopes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

University of Wisconsin, Madison

Phase 1 Completed

Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡